PANOPLY: Omics-Guided Drug Prioritization Method Tailored to an Individual Patient.

MLA

Kalari, Krishna R., et al. “PANOPLY: Omics-Guided Drug Prioritization Method Tailored to an Individual Patient.” JCO Clinical Cancer Informatics, vol. 2, Oct. 2018, pp. 1–11. EBSCOhost, https://doi.org/10.1200/CCI.18.00012.

APA

Kalari, K. R., Sinnwell, J. P., Thompson, K. J., Tang, X., Carlson, E. E., Yu, J., Vedell, P. T., Ingle, J. N., Weinshilboum, R. M., Boughey, J. C., Wang, L., Goetz, M. P., & Suman, V. (2018). PANOPLY: Omics-Guided Drug Prioritization Method Tailored to an Individual Patient. JCO Clinical Cancer Informatics, 2, 1–11. https://doi.org/10.1200/CCI.18.00012

Chicago

Kalari, Krishna R., Jason P. Sinnwell, Kevin J. Thompson, Xiaojia Tang, Erin E. Carlson, Jia Yu, Peter T. Vedell, et al. 2018. “PANOPLY: Omics-Guided Drug Prioritization Method Tailored to an Individual Patient.” JCO Clinical Cancer Informatics 2 (October): 1–11. doi:10.1200/CCI.18.00012.